The prM glycoprotein is thought to be a chaperone for the proper folding, membrane association and assembly of the envelope protein (E) of flaviviruses. The prM-E and E proteins of the Japanese encephalitis virus (JEV) were expressed in insect cells using both the baculovirus-expression system and the transient expression method. Protein expression was analysed by Western blotting and the cytopathic effect was observed by microscopy. In the baculovirus-expression system the E protein, with or without the prM protein, induced syncytial formation in Sf9 cells. Transient expression of prM-E also induced syncytia in Sf9 cells. Immunofluorescence revealed that in presence of prM, E proteins were endoplasmic reticulum-like in distribution, while in the absence of prM, E proteins were located on the cell surface. Sucrose gradient sedimentation and Western blot analysis indicated that the E protein expressed with or without the prM protein was secreted into the culture medium in particulate form. The formation of virus-like particles (VLPs) in the medium was confirmed by electron microscopy and immunoelectron microscopy. The results suggest that the E protein of JEV in the absence of prM, retained its fusion ability, by either cell surface expression or formation of VLPs. Moreover, based on the observation that co-expression of prM-E in Sf9 cells induced considerable syncytial formation, a novel, safe and simple antiviral screening approach is proposed for studying inhibitory antibodies, peptides or small molecules targeting the JEV E protein.
INTRODUCTION
Japanese encephalitis, caused by the Japanese encephalitis virus (JEV), is one of the most important arboviral encephalitides, causing 30 000-50 000 infections and 10 000-15 000 deaths per year (Erlanger et al., 2009; Misra & Kalita, 2010) . JEV is a member of the genus Flavivirus, in the family Flaviviridae, in which the virions consist of a nucleocapsid surrounded by a lipid bilayer containing the envelope glycoprotein and the membrane protein (M). The M protein is derived from a glycosylated precursor membrane protein (prM) from a cleavage by a furin-like protease when immature virions are released via the secretory pathway (Mukhopadhyay et al., 2005) . It has been demonstrated that prM is required for the proper folding, membrane association and assembly of the flavivirus envelope (E) protein (Konishi & Mason, 1993; Lorenz et al., 2002) . The crucial role of the interaction between prM and E has been well documented (Li et al., 2008; Lin & Wu, 2005; Zheng et al., 2010) . Co-expression of prM and E has been successfully used to produce virus-like particles (VLPs) of flaviviruses, offering a promising approach to the production of vaccines and diagnostic antigens (Kojima et al., 2003; Konishi et al., 2001; Yamaji et al., 2012; Zhang et al., 2007) . Moreover, this provides a model system for studying flavivirus envelope glycoprotein functions (Schalich et al., 1996) . Some inconsistent reports appeared to contradict the widely accepted idea that maturation of the flavivirus E protein requires the participation of prM. Thus, JEVMuLV pseudotyped viruses that expressed either the prM-E or E protein alone were constructed (Lee et al., 2009) . The authors found that these two different JEV-pseudotyped viruses showed similar infectivities and titres, suggesting that JEV-MuLV pseudotyped viruses did not require prM for the production of infectious virus. Also, expression of yellow fever virus (YFV) envelope protein in insect cells induced syncytial formation as a characteristic cytopathic effect, indicating that the fusion property of the YFV E protein was obviously retained without the participation of prM (Barros et al., 2011) . Furthermore, even though it lacked the stem region and transmembrane domains, expression of dengue-2 virus (DENV-2) E protein in yeast retained the inherent capacity to form VLPs and was able to elicit high-titres of neutralizing antibodies (Mani et al., 2013) .
It is interesting to elucidate the processing mechanisms involved in E protein expression and folding. In this study, we attempted to assess the role of prM in the maturation of JEV E in a baculovirus-expression system. Our research showed that JEV E protein expressed in Sf9 cells in the absence of prM induced syncytial formation by either surface expression or formation of VLPs, suggesting prMindependent processing to retain the fusion property. Moreover, based on the phenomenon of severe syncytial formation in insect cells, we established an approach for the rapid and safe screening of inhibitors, such as inhibitory peptides, antibodies or small molecules, which target the viral attachment or membrane fusion processes of JEV.
RESULTS

Construction of recombinant vAc-prME and vAc-E baculoviruses
The DNA sequences encoding JEV prME and E protein were cloned into baculoviruses under the control of a polyhedrin promoter (P PH ) and an op166 promoter (P op166 ), as previously described (Lin & Wu, 2005; Wang et al., 2010) (Fig. 1a) . In order to ensure the correct translocation of prM-E or E protein, as in an authentic infection (Allison et al., 1995; Markoff et al., 1994) , the expression cassette of prM-E included the SP1 signal peptide sequence derived from the C terminus of the Core (C) protein, and the expression cassette of E included the SP2 signal peptide derived from the C terminus of prM (Fig. 1a) . Correct construction of the recombinant baculoviruses vAc-prME and vAc-E was confirmed.
As shown in Fig. 1(b) the expression of prM and E protein in Sf9 cells infected with vAc-prME was detected by Western blot analysis using specific antibodies and the separated bands corresponded to proteins of molecular masses of 23 kDa and 53 kDa. In addition, a band of 76 kDa corresponding to uncleaved polyprotein prM-E was occasionally detected. In contrast, only the E protein with a molecular mass of 53 kDa was detected in Sf9 cells infected with vAc-E. Detection of the baculovirus capsid protein VP39 confirmed that infection was otherwise normal.
JEV E expression with or without prM triggers syncytial formation in Sf9 cells
Following infection with either of the recombinant baculoviruses, vAc-prME or vAc-E, the Sf9 cells displayed the formation of multinucleated syncytial cells (Fig. 2a) , which was a typical cytopathic effect of JEV infection (Fu & Zhang, 1996; Kim et al., 2004) . On the other hand, the Sf9 cells infected with control baculovirus vAc-Bac did not form syncytia. This suggested that syncytial formation was induced by the expression of E protein, with or without the participation of prM.
In order to exclude the possibility of a synergistic effect of baculovirus proteins on syncytial formation, plasmids containing the JEV prME or E gene were constructed and used to transfect Sf9 cells. The result showed that the transient expression of prM-E induced syncytial formation as expected, confirming that syncytia were induced by prM-E expression independent of baculoviral proteins (Fig.  2b) . In this case, however, we did not observe clear syncytial formation in Sf9 cells transiently expressing only the E protein (Fig. 2b) . This was probably due to the low (Fig. S1 , available in the online Supplementary Material).
Intracellular localization of JEV E
To better understand the underlying mechanisms of syncytial formation induced by JEV E, the subcellular localization of E protein in Sf9 cells was investigated by confocal laser scanning microscopy. Sf9 cells infected with vAc-prME, vAc-E or with the JEV control were stained with E-specific anti-DIII antibody. The fluorescent images obtained by confocal laser scanning microscopy revealed that the E proteins in Sf9 cells infected with JEV or vAc-prME showed an endoplasmic reticulum (ER)-like distribution. However, in vAc-E infected cells, a large portion of E protein was localized to cell surface (Fig. 3a) .
To confirm the cell surface expression of E in absence of prM, fixed but unpermeabilized cells were immunostained with anti-DIII antibody. As indicated in Fig.  3 (b), in JEV or vAc-prME infected cells, E proteins could hardly be detected, while in vAc-E infected cells, E proteins were clearly detected in unpermeabilized and in permeabilized cells. The results, therefore, indicate that the prM plays an important role in the ER-retention of E, and in the absence of prM, the E protein tends to localize to cell surface, which might contribute to syncytial formation.
JEV E forms VLPs independently of prM
Since our data showed that little E protein was detected on the surface of vAc-prME infected cells, and since it has been also been established that the co-expression of JEV prM and E protein generates VLPs (Yamaji & Konishi, 2013; Yamaji et al., 2012) , we therefore theorize that the observed syncytium in vAc-prME infected cells were induced by these VLPs in a 'fusion-from-without' manner (Bratt & Gallaher, 1969) .
To validate this, supernatants of Sf9 cells infected with vAcprME were collected and centrifuged to eliminate cell debris. The clarified supernatants were precipitated with PEG6000 and the pellet was collected for Western blot analysis. The E protein was clearly detected (Fig. 4a) . Also, both prM and cleaved pr fragment were detected ( Fig. 4a) , suggesting the formation of a mixture of mature and immature VLPs in the supernatant. However, we also detected the E protein in the pellet of supernatant of vAc-E infected Sf9 cells (Fig. 4a ). This suggested that in the vAc-Bac vAc-prME pIZ/V5-pHsp70 pIZ/V5-pHsp70-prME pIZ/V5-pHsp70-E vAc-E Fig. 2 . Induction of syncytial formation by JEV glycoproteins. Morphology of Sf9 cells at (a) 72 h after infection with vAc-prME, vAc-E or vAc-Bac, and (b) 48 h after transfection with plasmids expressing JEV prM-E, E only or a 'no-insert' control. Magnification, ¾100 (a, upper panels; b); ¾200 (a, lower panels).
absence of prM, expression of JEV E was released into the culture medium.
In order to investigate the nature of secreted E protein, the pellets were subjected to continuous sucrose gradient sedimentation. As shown in Fig. 4 (b), E protein expressed either in the presence or absence of prM peaked in the middle fractions, confirming that in the absence of prM, E protein was secreted in a particulate form. This is in addition to it being co-expressed in the form of prM-E, as reported previously (Yamaji & Konishi, 2013; Yamaji et al., 2012) . It was noteworthy that the distribution of E antigen was not correlated with the distribution of GP64 and VP39, which represented the envelope and the capsid of the baculovirus, respectively, suggesting that the presence of the particulate form of JEV E was not simply due to incorporation into baculovirus particles.
Electron microscopic observation of VLPs
The Sf9 cells infected with recombinant baculoviruses were harvested at 72 h post-infection (p.i.) and observed by electron microscopy (EM). As indicated in Fig. 5(a) , Sf9 cells infected with vAc-prME or vAc-E exhibited vesicles full of spherical particles presumed to be VLPs. In contrast, Sf9 cells infected with vAc-Bac and healthy Sf9 cells exhibited no, or empty vacuoles. In addition, samples from E-antigen-rich fractions obtained by sucrose gradient sedimentation were also collected for EM visualization.
The EM results obtained after negative staining with phosphotungstic acid showed similarly that baculovirus expression of prM-E or E in Sf9 cells yielded ordered spherical particles with a diameter of about 30-50 nm, indicative of VLPs (Fig. 5b) . Immunoelectron microscopy (IEM) using anti-DIII further confirmed that JEV E proteins located in these particles (Fig. 5b) . All the results, therefore, demonstrated that the expression of the E protein in Sf9 cells, with or without the prM protein, could produce VLPs.
Syncytial formation was adapted to screen antiviral molecules
The observation that co-expression of prM-E resulted in syncytial formation has implications in the development of a platform to screen antiviral molecules targeting the E protein of JEV, which is an important target for inhibitors of virus entry (Costin et al., 2010) .
In order to test this system, five types of rabbit polyclonal antibodies were used; three were specific to the E protein, whereas the other two were specific to either the pr fragment or the NS1 protein of JEV. We observed that the three antibodies against the JEV E (anti-Efl, anti-DI/DII and anti-DIII) severely inhibited syncytial formation in a dose-dependent manner. At a concentration of 1.25 mg ml 21 they completely abolished syncytial formation. In contrast, neither of the antibodies unrelated to E protein (anti-pr and anti-NS1) had any effect on syncytial formation, even at a concentration as high as 1.25 mg ml 21 (Fig.  6a) . By counting the number of syncytia in a random field of view, statistical analysis clearly revealed the inhibitory effect, as indicated in Fig. 6(b) . These results, therefore, proved that the system effectively distinguished the inhibitory reagents from unrelated/ineffective ones, thus providing powerful evidence that it could be used for screening of antiviral inhibitors targeted at JEV E.
DISCUSSION
Present knowledge indicates that the prM protein may function as a chaperone for the E protein of viruses in the genus Flavivirus (Konishi & Mason, 1993; Lorenz et al., 2002; Mukhopadhyay et al., 2005) . However, our findings show that expression of E protein in the absence of prM retains its fusion ability, suggesting its correct folding.
In the present study, a baculovirus expression system was used to dissect the processing of JEV E in detail. This was appropriate, because Sf9 cells are permissive to JEV (Fu & Zhang, 1996; Kim et al., 2004) ; and the same system has been used for the functional analysis of the prM-E complex and of the GXXXG motif in the transmembrane segment of prM (Lin et al., 2010; Lin & Wu, 2005) . Recombinant baculoviruses expressing either prM-E or E proteins (i.e. vAc-prME or vAc-E) were independently constructed. These recombinant viruses induced multi-nucleation in Sf9 cells as a result of membrane fusion between neighbouring cells. Cells infected with control baculovirus vAc-Bac did not induce syncytia. Clearly, this phenomenon was likely to be due to the expression of prM-E or E proteins and the transient expression of prM-E proteins in Sf9 cells induced syncytial formation, thereby excluding the probable synergistic effect by baculoviral proteins. Although syncytial formation was scarcely observed in Sf9 cells transiently expressing the E protein alone, this could be explained by the lower expression level of the E protein in this transient expression system compared with the infection with the recombinant baculovirus vAc-E.
Viral fusion proteins induce cell-cell fusion mainly in two ways; 'fusion-from-within' (FFWI) or 'fusion-fromwithout' (FFWO), which respectively require either the availability of these fusion proteins at the cell surface, or virus particles containing these proteins in the inoculum (Bratt & Gallaher, 1969) . Given our findings that the E proteins in vAc-prME infected Sf9 cells are located in the ER, and that co-expression of prM-E gives rise to VLPs that possess an inherent fusion ability (Guirakhoo et al., 1991; Schalich et al., 1996) , we suggest that in cells expressing prM-E, syncytial formation was induced by VLPs in a FFWO manner. In addition, E protein was detected both on the cell surface and in particulate form in Sf9 cells infected with vAc-E. Sucrose gradient centrifugation analysis suggested that the particles formed by E proteins were released into the culture medium independent of baculovirus, and EM/IEM observation revealed that these particles exhibited an ordered spherical shape with a diameter of 30-50 nm. Taking all these together, we suggest that the expression of the E protein in Sf9 without the participation of the prM protein might induce syncytial formation either by FFWI or FFWO, or by a combination of the two. In either case, it could be concluded that E protein retained its fusion ability independent of prM.
Furthermore, based on the phenomenon that co-expression of prM-E strongly induced syncytial formation, we developed a novel approach to screen anti-JEV agents, which can probably be extended to other flaviviruses. Nowadays, the worldwide prevalence of flavivirus infections has made their prevention and treatment a global public health priority. As there is no effective clinical therapeutic intervention in flaviviral infection, the identification of novel inhibitors to target the virus life cycle is urgently required (Geiss et al., 2009; Shi, 2002) . The E protein of flaviviruses mediates interactions between the virus and host cells during the initial stages of infection; hence it is widely targeted for the development of antiviral molecules, including inhibitory peptides (Bai et al., 2007; Costin et al., 2010; Hrobowski et al., 2005) , therapeutic antibodies (Thompson et al., 2009 ) and small molecules (Kampmann et al., 2009; Schmidt et al., 2012) . Here, we have established a new approach for antiviral screening targeted to JEV E, and in particular to its role in the attachment and fusion processes.
The validity of this method has been verified with several polyclonal antibodies. The results demonstrated that the antibodies specific to JEV E severely inhibited syncytial formation, but unrelated antibodies had no effect. It could be adapted for screening inhibitors targeted to the attachment and/or fusion processes of JEV. Avoiding the use of live viruses abates health risk to staff, which together with simple procedures and high effectiveness make it a potentially advantageous approach for the preliminary high-throughput screening of inhibitory peptides, antibodies and small molecules specific to JEV E.
In conclusion, we confirmed that expressed E protein retains its fusion ability in insect cells independent of prM, although the subcellular localization would tend to cell surface expression rather than retention in the ER. We also demonstrated that E protein without co-expression of prM could form VLPs. More practically, we established a novel, safe and simple approach to the screening of antiviral molecules specific to the E protein of JEV.
METHODS
Cell lines, viruses and antibodies. Spodoptera frugiperda Sf9 cells were cultivated at 28 uC in Grace's insect medium (Gibco) supplemented with 10 % FBS. BHK-21 cells were cultivated in Dulbecco's modified Eagle's medium supplemented with 10 % FBS at 37 uC in 5 % CO 2 . The JEV strain P3 (GenBank accession no.: U47032.1) was propagated in BHK-21 cells and stored at -80 uC. In some experiments, JEV was also grown in Sf9 cells. The control baculovirus vAc-Bac was generated by the Bac-To-Bac system (Invitrogen) and used as a kind of WT baculovirus without polyhedra.
The nucleotide sequence encoding the full-length E protein (500 aa, encoded by nucleotides 978-2477) was cloned by cloning the defined coding region in pET-32a vector (Novagen). The nucleotide sequences encoding the domain I/domain II (DI/DII) of JEV E (298 On: Sat, 26 Jan 2019 21:14:57 aa, encoded by nucleotides 978-1871), the domain III (DIII) of JEV E protein (102 aa, encoded by nucleotides 1872-2177) and the NS1 protein of JEV (352 aa, encoded by nucleotides 2478-3533) were cloned by fusing the defined coding regions with pET-28a (Novagen). The nucleotide sequence encoding the pr fragment of JEV (92 aa, encoded by nucleotides 477-752) was cloned by fusing the defined coding region with pGEX-KG (Amersham). The corresponding fusion proteins were all expressed in Escherichia coli BL21(DE3) pLysS and the purified proteins were used to generate rabbit polyclonal serum (Wang et al., 2008) . Antisera were designated anti-Efl, anti-DI/DII, anti-DIII, anti-NS1 and anti-pr. Polyclonal antibodies specific to GP64 and VP39 were used as previously described (Wang et al., 2008) . To perform antiviral analyses, antibodies were purified with Sepharose-protein A (NZKbio) according to the manufacturer's recommendations.
Construction of recombinant baculoviruses. The genomic RNA of the JEV P3 strain was extracted from the virus stock by using the TRIzol kit (Invitrogen), followed by reverse transcription with MMLV (Promega) to obtain the cDNAs of the prME-and E-coding genes using the following primers (i) for the prME gene, forward primer: 59-gcggaattcatgagaggaggaaatgaaggctcaat-39 and reverse primer: 59-gcgtctagattaagcatgcacattgttcgctaag-39 and (ii) for the E gene, forward primer: 59-gcggaattcatgcttggcagcaacaacggtcaac-39 and reverse primer: 59-gcgtctagattaagcatgcacattgttcgctaag-39. All the forward primers contained an EcoRI restriction site, and the reverse primers contained an XbaI restriction site for ligation to the pFastBac1-op166 vector (Wang et al., 2010) , generating pFB-op166-prME and pFB-op166-E separately. All of the sequences were confirmed by DNA sequence analysis (BGI). Plasmids pFB-op166-prME and pFBop166-E were used to transform DH10b cells by use of an AcBacmid and a helper plasmid expressing transposase (Bac-to-Bac Baculovirus Expression System; Gibco). Recombinant bacmids were selected by gentamicin resistance and blue/white screening. The correct recombinant bacmid DNA was identified by PCR using M13 primers and used to transfect Sf9 cells using Lipofectin according to the manufacturer's manual (Invitrogen). Five days post-transfection, the culture medium was harvested as a recombinant baculovirus stock.
SDS-PAGE and Western blot analyses. Sf9 cells were infected with recombinant baculoviruses at an m.o.i. of 5. At 3 days p.i., 1610 5 cells were collected and prepared for SDS-PAGE, followed by transfer to a PVDF membrane using a Trans-Blot apparatus (BioRad). Cells infected with vAc-Bac and healthy Sf9 cells were used as controls. Western blot analysis was performed with anti-DIII, anti-pr or anti-VP39 as a primary antibody, and HRP-conjugated goat antirabbit antibody as a secondary antibody. The antibody-protein complexes were visualized with SuperSignal West Pico Chemiluminescent Substrate (Fermentas) and the MicroChemi Bio-imaging System (DNR).
To detect E antigens in the supernatant of recombinant baculoviruses-infected Sf9 cells, 2 ml supernatants from recombinant baculovirus-infected Sf9 cells at 4 days p.i. were clarified by centrifugation at 8000 g for 10 min, and then incubated with 10 % (w/v) polyethylene glycol 6000 at 4 uC for at least 8 h. After centrifugation at 8000 g for 30 min, the pellets were prepared and subjected to SDS-PAGE followed by Western blot analysis as described above. Supernatants from vAc-Bac infected cells were used as a control.
Construction of recombinant plasmids, and transfection assay.
The promoter of Drosophila Hsp70 (pHsp70) was amplified from plasmid pAcDZ1 (Zuidema et al., 1990) using the forward primer: 59-gcgaagctttagaatcccaaaacaactggttat-39 and the reverse primer: 59-gcgaagcttattcagagttctcttcttgtattca-39. The product was digested with HindIII and ligated to HindIII-digested pIZ/V5-His to construct pIZ/V5-pHsp70. The fragments of prME and E obtained as described above were then inserted separately into EcoRI/XbaI-linearized pIZ/V5-pHsp70, in order to generate pIZ/V5-pHsp70-prME and pIZ/V5-pHsp70-E.
For the transfection assay, Sf9 cells were inoculated into 24-well tissue culture plates at a density of 2610 5 cells per well. After 2 h, cells were transfected with 2 mg of recombinant plasmid DNA, using 3 ml of Lipofectin according to the manufacturer's manual (Invitrogen). At 18 h post-transfection (p.t.), the plates were heat shocked at 42 uC for 30 min. At 48 h p.t., the cellular cytopathic effects were observed and analysed.
Immunofluorescence. Sf9 cells grown on coverslips were infected with JEV or appropriate recombinant or control baculoviruses at an m.o.i. of 1. At 36 h p.i., cells were fixed for 15 min with paraformaldehyde (4 % in PBS). A sample of fixed cells was made permeable for 15 min at room temperature with PBS containing 0.5 % Triton X-100. A second sample was not treated with Triton X-100. Cells were then stained with anti-DIII followed by goat-antirabbit (FITC-conjugated; Proteintech) immunoglobulin.
Sucrose gradient sedimentation analysis for secreted E antigens. Supernatants (50 ml) from recombinant baculovirus-infected Sf9 cells at 4 days p.i. were clarified and concentrated with polyethylene glycol 6000 as described above, and then subjected to a continuous sucrose gradient (10-50 %, w/w), followed by centrifugation at 4 uC and 247 605 g for 8 h (SW41 rotor; Beckman). Fractions were collected from the bottom of the tube and subjected to SDS-PAGE and Western blot analysis in order to determine the concentration of E antigen, using anti-Efl together with the concentrations of two baculovirus structural proteins, GP64 and VP39, which were representative of the envelope and capsid of baculovirus, respectively.
Electron microscopy (EM). Sf9 cells infected with recombinants or with WT baculovirus vAc-Bac, were harvested at 72 h p.i., and prepared for EM as previously described (Luo et al., 2011) . Healthy cells were used as a control.
To observe the secreted VLPs, 5 ml of VLP preparations from the appropriate fractions of the sucrose sedimentation was adsorbed for 3 min onto Formvar carbon-coated copper grids. The excess was removed and bound particles were washed with three drops of distilled water and then stained with 1 % (w/v) uranyl acetate (pH 4.5) for 30 s. The grids were air-dried and examined with a transmission electron microscope (H-7000 FA; Hitachi).
IEM was performed as previously described (Deng et al., 2007) . Briefly, 5 ml of VLP preparations were added to carbon-coated nickel grids (150 mesh) and blocked with 5 % BSA. The primary antibodies were purified anti-DIII at a concentration of 0.1 mg ml 21 . Twelvenanometer Colloidal Gold-AffiniPure goat anti-rabbit immunoglobulin G (Jackson ImmunoResearch) was used as the secondary antibody for hybridization. The grids were then negatively stained and examined with a transmission electron microscope as described above.
Antiviral determination. Sf9 cells were infected with the recombinant baculovirus vAc-prME at an m.o.i. of 0.01, together with individual candidates of inhibitory reagents at specified concentrations. The mixtures were then immediately seeded onto 96-well plates in parallel at 5000 cells per well. The effects of the inhibitors on syncytial formation were then monitored at 3 or 4 days p.i., and statistical analyses were undertaken.
